No changes in striatal dopamine transporter in antidepressant-treated patients with major depression

研究成果: Article同行評審

5 引文 斯高帕斯(Scopus)

摘要

Selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors are the mainstay treatment for major depressive disorder, but whether their therapeutic mechanisms involve the dopaminergic system remains inconclusive. Eight participants with major depressive disorder were administered single-photon emission computed tomography with [Tc] TRODAT-1 both before and after 24 weeks of antidepressant treatment to evaluate the change in striatal dopamine transporter (DAT) availability. All participants were responders (≥50% reduction in Hamilton Depression Rating Scale score). The DAT availability did not change (P=0.58), as the Hamilton Depression Rating Scale score decreased (P=0.02). Striatal DAT availability remains intact during long-term antidepressant treatment in patients with major depressive disorder.

原文English
頁(從 - 到)141-144
頁數4
期刊International Clinical Psychopharmacology
28
發行號3
DOIs
出版狀態Published - 2013 五月 1

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Pharmacology (medical)

指紋 深入研究「No changes in striatal dopamine transporter in antidepressant-treated patients with major depression」主題。共同形成了獨特的指紋。

引用此